Table 1.
Baseline characteristics.
| -SRI (N=80) N (%) |
+SRI (N=45) N (%) |
χ 2 | p | |
|---|---|---|---|---|
| Gender (male) | 44 (55) | 26 (58) | 0.090 | 0.764 |
| Hypertension | 21 (26) | 18 (40) | 2.537 | 0.111 |
| Diabetes | 15 (18.75) | 11 (24) | 0.567 | 0.451 |
| Congestive Heart Failure | 7 (8.75) | 3 (6.67) | 0.170 | 0.680 |
| Stroke/TIA | 15 (18.75) | 8 (17.78) | 0.018 | 0.893 |
| COPD/asthma | 13 (16.25) | 13 (28.9) | 2.793 | 0.095 |
| Epilepsy | 34 (42.5) | 23 (51) | 0.861 | 0.353 |
| Focal epilepsy | 31 (38.75) | 18 (40) | 0.019 | 0.891 |
| Generalized epilepsy | 2 (2.5) | 2 (4.44) | 0.352 | 0.553 |
| Undetermined epilepsy | 1 (1.25) | 3 (6.67) | 2.728 | 0.099 |
| Tobacco | 4 (5) | 0 (0) | 2.324 | 0.127 |
| Alcohol | 0 (0) | 0 (0) | ------ | ------ |
| Drug Abuse | 3 (3.75) | 1 (2) | 0.217 | 0.641 |
| Opioids | 3 (3.75) | 1 (2) | 0.217 | 0.641 |
| Benzodiazepines | 17 (21.25) | 13 (28.9) | 0.921 | 0.337 |
| Non-benzodiazepines | 9 (11.25) | 4 (9) | 0.172 | 0.678 |
| AED∗ | 41 (51.25) | 32 (71.11) | 7.898 | 0.048 |
|
| ||||
| Mean ± SD | Mean ± SD | CI | P | |
|
| ||||
| Age (years)∗ | 57.73±14.43 | 62.51±10.36 | -9.21- -0.366 | 0.034 |
| Body Mass Index | 30.86±6.13 | 30.95±5.91 | -2.30-2.14 | 0.942 |
SRI: serotonin reuptake inhibitor, TIA: transient ischemic attack, COPD: chronic obstructive pulmonary disease, and AED: antiepileptic drug; ∗: p<0.05.